[12] Kurkin DV, Bakulin DA, Morkovin EI, Kalatanova AV, Makarenko IE, Dorotenko AR, Kovalev NS, Dubrovina MA, Verkholyak DV, Abrosimova EE, Smirnov AV, Shmidt MV, Tyurenkov IN
IM bioavailability: 14-19% (rats) vs 45-51% (dogs): human figure unknown
Notice that you're new to the forum so...if you have any questions or need any help, put up a new post so that all forum members can see it and people will be along to help (your comment here will only be seen by the person who wrote this post and anyone who happens to read it - not the whole forum)
Michaelis typically starts patients at doses well below labeled recommendations, with weekly injections and frequent follow-ups
Why It's Unique Designed to support steady progress with a familiar, well-established mechanism that fits easily into long-term routines